No they are not recommending it. That points you to the clinical trials and approximate dosages used in those trials and any adjuncts. Physicians can prescribe off label if it's an already FDA approved drug.
Interesting of the 6 studies I see in the US 4 are recruiting, 1 is not yet recruiting and 1 has been withdrawn.
I searched on the one withdrawn and got this:
Investigations have led to the withdrawal of a study backing ivermectin to treat COVID-19. But that’s not the last time we’ll hear about this controversial drug.
theconversation.com